# Pregnancy and Vaccination This page contains all datasets in the **Pregnancy & Vaccination** category of the CDC Open Data Catalog. **Total Datasets in Category**: 13 **Last Updated**: 5/24/2026 ## Datasets in this Category * [Data: COVID-19 vaccination among pregnant people aged 18-49 years overall, by race and ethnicity, and date reported to CDC - Vaccine Safety Datalink,\* United States](#data-covid-19-vaccination-among-pregnant-people-aged-18-49-years-overall-by-race-and-ethnicity-and-date-reported-to-cdc-vaccine-safety-datalink-united-states) * [Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of Nirsevimab, and Intent for Nirsevimab Receipt, United States](#infant-protection-against-respiratory-syncytial-virus-rsv-by-maternal-rsv-vaccination-or-receipt-of-nirsevimab-and-intent-for-nirsevimab-receipt-united-states) * [Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of RSV Monoclonal Antibody, and Intent for RSV Monoclonal Antibody Receipt Reported by Females Aged 18-49 Years Who Have an Infant <8 Months During the RSV](#infant-protection-against-respiratory-syncytial-virus-rsv-by-maternal-rsv-vaccination-or-receipt-of-rsv-monoclonal-antibody-and-intent-for-rsv-monoclonal-antibody-receipt-reported-by-females-aged-18-49-years-who-have-an-infant-8-months-during-the-rsv) * [Monthly Cumulative Influenza Vaccination Coverage, by Race/Ethnicity, Pregnant Persons 18 years to 49 years, United States](#monthly-cumulative-influenza-vaccination-coverage-by-raceethnicity-pregnant-persons-18-years-to-49-years-united-states) * [Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant, United States](#monthly-nirsevimab-receipt-and-intent-among-females-aged-18-49-years-who-have-a-baby-8-months-are-currently-pregnant-or-are-trying-to-get-pregnant-united-states) * [Percent of Pregnant Women Ages 18 –49 Years Who have Received an Influenza Vaccine Overall, by Race and Ethnicity, and Season](#percent-of-pregnant-women-ages-18-49-years-who-have-received-an-influenza-vaccine-overall-by-race-and-ethnicity-and-season) * [Percent of Pregnant Women Ages 18-49 Years Who Have Received a COVID-19 Vaccine Overall, by Race and Ethnicity, and Season](#percent-of-pregnant-women-ages-18-49-years-who-have-received-a-covid-19-vaccine-overall-by-race-and-ethnicity-and-season) * [State Specific Influenza Vaccination Coverage Among Women With Live Birth- PRAMS, 2009-10 Influenza Season](#state-specific-influenza-vaccination-coverage-among-women-with-live-birth-prams-2009-10-influenza-season) * [Vaccination Coverage among Pregnant Women](#vaccination-coverage-among-pregnant-women) * [Weekly COVID-19 Vaccination Coverage among Pregnant Women by Race and Ethnicity](#weekly-covid-19-vaccination-coverage-among-pregnant-women-by-race-and-ethnicity) * [Weekly Data: COVID-19 vaccination among pregnant people ages 18-49 years before and during pregnancy overall, by race/ethnicity, and week ending date - Vaccine Safety Datalink,\* United States](#weekly-data-covid-19-vaccination-among-pregnant-people-ages-18-49-years-before-and-during-pregnancy-overall-by-raceethnicity-and-week-ending-date-vaccine-safety-datalink-united-states) * [Weekly Percent of Pregnant Women Ages 18-49 Years Vaccinated with Respiratory Syncytial Virus (RSV) Vaccine Overall and by Race and Ethnicity](#weekly-percent-of-pregnant-women-ages-18-49-years-vaccinated-with-respiratory-syncytial-virus-rsv-vaccine-overall-and-by-race-and-ethnicity) * [Weekly Respiratory Syncytial Virus (RSV) Vaccination Coverage among Pregnant Women by Race and Ethnicity](#weekly-respiratory-syncytial-virus-rsv-vaccination-coverage-among-pregnant-women-by-race-and-ethnicity) *** #### Data: COVID-19 vaccination among pregnant people aged 18-49 years overall, by race and ethnicity, and date reported to CDC - Vaccine Safety Datalink,\* United States * **Description**: Estimates are for pregnant persons who are up-to-date with COVID-19 vaccines, overall and by race and ethnicity based on data from the Vaccine Safety Datalink\*. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: covid19\_vaccination\_pregnant\_people\_rac\_\_hv7b\_3sw8 * **Dataset ID**: hv7b-3sw8 * **Category**: Pregnancy & Vaccination * **Total Rows**: 286 * **Last Refresh**: 7/12/2025 * **Total Batches**: 1 * **Tags**: * **Source Data**: #### Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of Nirsevimab, and Intent for Nirsevimab Receipt, United States * **Description**: Infant Protection Against RSV by Maternal RSV Vaccination or Receipt of Nirsevimab and Intent for Nirsevimab Receipt, Reported by Females Aged 18-49 Years Who Have an Infant <8 Months During the RSV Season (born since April 1, 2024) Monthly estimates of infant protection against RSV by maternal RSV vaccination or receipt of nirsevimab, as well as intent for nirsevimab receipt, were calculated using data from the from the National Immunization Survey–Adult COVID Module (NIS–ACM). (). Data were reported by adult females aged 18-49 years with infants under the age of 8 months during the RSV season (born since April 1, 2024). The NIS–ACM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older. All estimates are based upon parent-reported receipt of nirsevimab. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: infant\_protection\_rsv\_maternal\_vaccinat\_\_vdz4\_qrri * **Dataset ID**: vdz4-qrri * **Category**: Pregnancy & Vaccination * **Total Rows**: 656 * **Last Refresh**: 7/9/2025 * **Total Batches**: 26 * **Tags**: iis, iqvia, nis-acm, nis-flu, rsv vaccination, vsd * **Source Data**: #### Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of RSV Monoclonal Antibody, and Intent for RSV Monoclonal Antibody Receipt Reported by Females Aged 18-49 Years Who Have an Infant <8 Months During the RSV * **Description**: • Infant Protection Against RSV by Maternal RSV Vaccination or Receipt of Monoclonal Antibody, and Intent for RSV Monoclonal Antibody Receipt, Reported by Females Aged 18-49 Years Who Have an Infant <8 Months During the RSV Season (Born Since April 1, 2025), by Month of Interview • Monthly estimates of infant protection against RSV by maternal RSV vaccination or infant receipt of RSV monoclonal antibody (nirsevimab or clesrovimab), as well as intent for RSV monoclonal antibody receipt, were calculated using data from the National Immunization Surveys (NIS) – Fall Respiratory Virus Module (NIS–FRVM). The NIS–FRVM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older. Data were reported by adult females aged 18–49 years with infants under the age of 8 months during the RSV season (born since April 1, 2025). All estimates are based upon parent-reported receipt of RSV monoclonal antibody. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: infant\_protection\_rsv\_maternal\_vaccinat\_\_7nbz\_eajm * **Dataset ID**: 7nbz-eajm * **Category**: Pregnancy & Vaccination * **Total Rows**: 125 * **Last Refresh**: 3/12/2026 * **Total Batches**: 8 * **Tags**: nis-acm, cms, iqvia, iis, rsv vaccination, vsd * **Source Data**: #### Monthly Cumulative Influenza Vaccination Coverage, by Race/Ethnicity, Pregnant Persons 18 years to 49 years, United States * **Description**: Monthly Cumulative Influenza Vaccination Coverage, by Race/Ethnicity, Pregnant Persons 18 years to 49 years, United States * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: monthly\_cumulative\_influenza\_vaccinatio\_\_9wzx\_rwzv * **Dataset ID**: 9wzx-rwzv * **Category**: Pregnancy & Vaccination * **Total Rows**: 21 * **Last Refresh**: 7/12/2025 * **Total Batches**: 1 * **Tags**: flu, influenza, pregnant persons, vaccine coverage * **Source Data**: #### Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant, United States * **Description**: Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant. • Using data from the National Immunization Survey-Adult COVID Module (NIS-ACM), monthly estimates of receipt and intent for baby’s receipt of nirsevimab reported by females aged 18-49 years with infants under the age of 8 months, females aged 18-49 years who are currently pregnant, and females aged 18-49 years who are currently trying to get pregnant. • The NIS-ACM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: monthly\_nirsevimab\_receipt\_intent\_femal\_\_8ame\_63pc * **Dataset ID**: 8ame-63pc * **Category**: Pregnancy & Vaccination * **Total Rows**: 60 * **Last Refresh**: 7/12/2025 * **Total Batches**: 1 * **Tags**: nis-acm, pregnancy, rsv vaccination * **Source Data**: #### Percent of Pregnant Women Ages 18 –49 Years Who have Received an Influenza Vaccine Overall, by Race and Ethnicity, and Season * **Description**: Weekly influenza vaccination coverage estimates for pregnant women ages 18–49 years are based on electronic health record (EHR) data from the Vaccine Safety Datalink (VSD), a collaboration between CDC's Immunization Safety Office and multiple integrated health care organizations. The denominator includes women with a pregnancy during the current flu season (defined as August through March) beginning before or during the specified week. The numerator includes those who received a flu vaccine since July 1 of the respective flu season before or during pregnancy as of the specified week ending date. Pregnant women are not removed from the numerator or denominator when the pregnancy ends. Cumulative vaccination coverage for one week may be lower than cumulative coverage for a previous week due to the addition of pregnant women in the denominator. Additionally, no requirements for length of enrollment in a VSD site are applied, and vaccinations given outside of a VSD site might not be included. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: weekly\_influenza\_vacc\_coverage\_pregnant\_\_8fbp\_accd * **Dataset ID**: 8fbp-accd * **Category**: Pregnancy & Vaccination * **Total Rows**: 59,706 * **Last Refresh**: 5/20/2026 * **Total Batches**: 31 * **Tags**: vsd, flu vaccination, iis, iqvia, nis-acm, nis-flu * **Source Data**: #### Percent of Pregnant Women Ages 18-49 Years Who Have Received a COVID-19 Vaccine Overall, by Race and Ethnicity, and Season * **Description**: Weekly COVID-19 Vaccination Coverage, Pregnant Women 18-49 Years Old by Overall, by Race and Ethnicity, and Season Weekly COVID-19 vaccination coverage estimates for pregnant women ages 18–49 years are based on electronic health record (EHR) data from the Vaccine Safety Datalink (VSD), a collaboration between CDC's Immunization Safety Office and multiple integrated health care organizations.\*  The denominator includes women with a pregnancy during the respective season† beginning before or during the specified week. The numerator includes those who received a COVID-19 vaccine after the vaccine was available for the respective season‡ before or during pregnancy as of the specified week ending date. Pregnant women are not removed from the numerator or denominator when the pregnancy ends. Cumulative vaccination coverage for one week may be lower than cumulative coverage for a previous week due to the addition of pregnant women in the denominator.§ Additionally, no requirements for length of enrollment in a VSD site are applied, and vaccinations given outside of a VSD site might not be included.± Weekly comparisons to previous season should take into account differences between seasons in vaccine availability dates.‡ * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: weekly\_covid\_vaccination\_coverage\_pregn\_\_pvk6\_8bzd * **Dataset ID**: pvk6-8bzd * **Category**: Pregnancy & Vaccination * **Total Rows**: 23,783 * **Last Refresh**: 5/20/2026 * **Total Batches**: 31 * **Tags**: iis, covid-19 vaccination, nis-acm, vsd, iqvia * **Source Data**: #### State Specific Influenza Vaccination Coverage Among Women With Live Birth- PRAMS, 2009-10 Influenza Season * **Description**: For more information about the Pregnancy Risk Assessment Monitoring System please visit . See for the MMWR article. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: state\_specific\_influenza\_vaccination\_co\_\_mmi4\_8ajr * **Dataset ID**: mmi4-8ajr * **Category**: Pregnancy & Vaccination * **Total Rows**: 29 * **Last Refresh**: 7/12/2025 * **Total Batches**: 1 * **Tags**: flu shot, immunization, prams, pregnant women * **Source Data**: #### Vaccination Coverage among Pregnant Women * **Description**: Vaccination Coverage among Pregnant Women • Data on influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination coverage at the state level from the Pregnancy Risk Assessment Monitoring System (PRAMS) for women who had a recent live birth by age and race/ethnicity. • Additional information available at and * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: vaccination\_coverage\_pregnant\_women\_\_h7pm\_wmjc * **Dataset ID**: h7pm-wmjc * **Category**: Pregnancy & Vaccination * **Total Rows**: 13,975 * **Last Refresh**: 7/12/2025 * **Total Batches**: 3 * **Tags**: immunization, influenza, pregnancy & vaccinations, td, tdap * **Source Data**: #### Weekly COVID-19 Vaccination Coverage among Pregnant Women by Race and Ethnicity * **Description**: Weekly COVID-19 Vaccination Coverage, Pregnant Women 18-49 Years Old • COVID-19 vaccination coverage among pregnant women is assessed through the Vaccine Safety Datalink\* • Data on updated 2023-24 COVID-19 vaccinations among pregnant women was available starting September 23, 2023, and includes doses received starting September 14, 2023. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: weekly\_covid\_vaccination\_coverage\_pregn\_\_efqg\_e273 * **Dataset ID**: efqg-e273 * **Category**: Pregnancy & Vaccination * **Total Rows**: 612 * **Last Refresh**: 7/12/2025 * **Total Batches**: 2 * **Tags**: adult, covid-19 vaccination, pregnancy, vsd * **Source Data**: #### Weekly Data: COVID-19 vaccination among pregnant people ages 18-49 years before and during pregnancy overall, by race/ethnicity, and week ending date - Vaccine Safety Datalink,\* United States * **Description**: These weekly COVID-19 vaccination coverage estimates are for pregnant persons who are fully vaccinated before and during pregnancy based on data from the Vaccine Safety Datalink\*. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: weekly\_covid19\_vaccination\_pregnant\_peo\_\_w6be\_99qd * **Dataset ID**: w6be-99qd * **Category**: Pregnancy & Vaccination * **Total Rows**: 1,144 * **Last Refresh**: 7/12/2025 * **Total Batches**: 1 * **Tags**: * **Source Data**: #### Weekly Percent of Pregnant Women Ages 18-49 Years Vaccinated with Respiratory Syncytial Virus (RSV) Vaccine Overall and by Race and Ethnicity * **Description**: Weekly RSV Vaccination Coverage, Pregnant Women 18-49 Years Old by Race and Ethnicity Weekly RSV vaccination coverage estimates for pregnant women 18–49 years are based on electronic health record (EHR) data from the Vaccine Safety Datalink (VSD), a collaboration between CDC's Immunization Safety Office and multiple integrated health care organizations.\* The denominator includes those who reached at least 32 weeks' gestation since September 1, 2025. The numerator includes those who have received an RSV vaccine during pregnancy as of the week ending date. Pregnant women are not removed from the numerator or denominator when the pregnancy ends. Cumulative vaccination coverage for one week may be lower than cumulative coverage for a previous week due to the addition of pregnant women in the denominator. Additionally, no requirements for length of enrollment in a VSD site are applied, and vaccinations given outside of a VSD site might not be included. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: weekly\_rsv\_vacc\_coverage\_pregnant\_race\_\_\_uqxy\_gepz * **Dataset ID**: uqxy-gepz * **Category**: Pregnancy & Vaccination * **Total Rows**: 5,012 * **Last Refresh**: 5/20/2026 * **Total Batches**: 27 * **Tags**: rsv vaccination, iis, iqvia, nis-acm, vsd * **Source Data**: #### Weekly Respiratory Syncytial Virus (RSV) Vaccination Coverage among Pregnant Women by Race and Ethnicity * **Description**: Weekly RSV Vaccination Coverage, Pregnant Women 18-49 Years Old • RSV vaccination coverage among pregnant women is assessed through the Vaccine Safety Datalink\* • Data on RSV vaccinations among pregnant women was available starting September 22, 2023, and includes doses received starting September 24, 2023. * **Snowflake Schema**: dwv\_preg\_vacc * **Databricks Schema**: cdc\_dwv\_preg\_vacc * **Table Name**: weekly\_rsv\_vacc\_coverage\_pregnant\_women\_\_g4jn\_64pd * **Dataset ID**: g4jn-64pd * **Category**: Pregnancy & Vaccination * **Total Rows**: 342 * **Last Refresh**: 7/12/2025 * **Total Batches**: 2 * **Tags**: pregnancy, rsv, vsd * **Source Data**: --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://docs.dataplex-consulting.com/data-catalog/cdc-open-data-product/cdc-pregnancy-and-vaccination.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.